|
Mentioned
|
NIH;ASSN OF AMER CANCER INST;OFF OF MANAGEMENT AND BUDGET;US CONGRESS;AMER ASSN FOR CANCER RESEARCH;AMER SOCIETY OF CLINICAL ONCOLOGY;ONCOLOGY NURSE FOUNDATION;MEAD JOHNSON;AMER COLLEGE OF SURGEONS;ARTHUR D LITTLE;S RESEARCH INST;INST JULES BORDET BELGIUM;ROXANE LABORATORIES;YAMANOUCHI PHARMACEUTICAL;FDA;MAXIMA;MELOY LABORATORIES;LITTON BIONETICS;JWK INTL;UNIV AZ;INST OF LABORATORY ANIMAL RESOURCES;NATL ACADEMY OF SCIENCES;MICROBIAL CHEMISTRY RESEARCH FOUNDATION JAP;BRANDT E, US GOVT;CALABRESI P, NCI;CHABNER B, NCI;DAVIS C, HEALTH CARE FINANCE ADMINISTRATION;DRISCOLL J, NCI;DUGAN W, ASSN OF COMMUNITY CANCER CENTERS;ELION G, NCI;GLATSTEIN E, NCI;GOLDMAN D, NCI;GRIESHABER C, NCI;HELLMAN S, NCI;KATTERHAGEN G, NATL CANCER ADVISORY BOARD;LEVENTHAL B, NCI;MAHER M, HEALTH CARE FINANCE ADMINISTRATION;MARKS P, NCI;MCKAY F, FOX CHASE CANCER CENTER;MOORE P, ONCOLOGY NURSING SOCIETY;MORTENSON L, ASSN OF COMMUNITY CANCER CENTERS;PHILLIPS T, UNIV CA SAN FRANCISCO;RACKER E, NCI;REAGAN, US GOVT;SHELINE G, UNIV CA SAN FRANCISCO;SUFFNESS M, NCI;WACHHOLZ B, NCI;WILSON G, UNIV CA LOS ANGELES;WINN R, ST BARNABAS HOSPITAL;YARBRO CH, ONCOLOGY NURSING SOCIETY
|